Laurus Labs Limited Laurus Labs Limited

Laurus Labs Limited

LAURUSLABS

Rankning i aktier #1746
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Aktiekurs
$22.83
Senast synkroniserad: 2026-10-19
Marknadsvärde
$12.34B
Förändring (1 dag)
0.51%
Förändring (1 år)
117.95%
Land
IN
Handel Laurus Labs Limited (LAURUSLABS)

Kategori

Healthcare
Historik för aktiesplit för Laurus Labs Limited (LAURUSLABS)
Aktien Laurus Labs Limited (symbol: LAURUSLABS) har genomgått totalt 1 aktiesplitar.
Den senaste spliten skedde den Sep 29, 2020.
En LAURUSLABS-aktie köpt före Sep 29, 2020 motsvarar nu 5 LAURUSLABS-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
2020-09-29 5:1 x5 x5
Aktiesplitar för liknande företag eller konkurrenter